Neuroprotective Factors of the Retina and Their Role in Promoting Survival of Retinal Ganglion Cells: A Review

• Published in: Ophthalmic research Vol. 64; no. 3; pp. 345 - 355
• Main Authors: Fudalej, Ewa, Justyniarska, Magdalena, Kasarełło, Kaja, Dziedziak, Jacek, Szaflik, Jacek P., Cudnoch-Jędrzejewska, Agnieszka
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland S. Karger AG 01.06.2021
• Subjects: Apoptosis; Ciliary neurotrophic factor; Endothelial growth factors; Ganglion; Glaucoma; Hypertension; Nerve growth factor; Neurons; Review Article; Neuroprotection; Retinal ganglion cells; Pathology; Retina; Neurodegeneration
• ISSN: 0030-3747; 1423-0259; 1423-0259
• DOI: 10.1159/000514441

Retinal ganglion cells (RGCs) play a crucial role in the visual pathway. As their axons form the optic nerve, apoptosis of these cells causes neurodegenerative vision loss. RGC death could be triggered by increased intraocular pressure, advanced glycation end products, or mitochondrial dysfunction. In this review, we summarize the role of some neuroprotective factors in RGC injury: ciliary neurotrophic factor (CNTF), nerve growth factor (NGF), brain-derived neurotrophic factor, vascular endothelial growth factor, pigment epithelium-derived factor, glial cell line-derived neurotrophic factor, and Norrin. Each, in their own unique way, prevents RGC damage caused by glaucoma, ocular hypertension, ischemic neuropathy, and even oxygen-induced retinopathy. These factors are produced mainly by neurons, leukocytes, glial cells, and epithelial cells. Neuroprotective factors act via various signaling pathways, including JAK/STAT, MAPK, TrkA, and TrkB, which promotes RGC survival. Many attempts have been made to develop therapeutic strategies using these factors. There are ongoing clinical trials with CNTF and NGF, but they have not yet been accepted for clinical use.